NCT06063330 Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects Status COMPLETED Phase PHASE1
NCT06057025 Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition. Status UNKNOWN Phase PHASE3
NCT06052527 Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning Status COMPLETED Phase N/A
NCT06050460 SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19 Status UNKNOWN Phase PHASE1
NCT06048393 SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People Status UNKNOWN Phase PHASE1
NCT06044233 A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT06043882 Number of Participants Diagnosed With Sarcoidosis by Bronchoscopic Transbronchial Needle Aspiration After COVID- 2019 . Status COMPLETED Phase N/A
NCT06042881 Retrospective Cohort Study of the Physiotherapy in Critically Ill Covid Patients Status UNKNOWN Phase N/A
NCT06039449 A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2 Status COMPLETED Phase PHASE3
NCT06039163 A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19 Status COMPLETED Phase PHASE1
NCT06038682 Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure Status COMPLETED Phase N/A
NCT06033560 The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure Status UNKNOWN Phase N/A
NCT06030414 A Study to Determine the Tolerability of Intranasal LMN-301 Status COMPLETED Phase PHASE1
NCT06027229 Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations Status COMPLETED Phase PHASE2
NCT06022224 A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL Status TERMINATED Phase PHASE2/PHASE3